Filter Results :

Your search for Pharma returned 24829 reports

Sort by


Sudan and South Sudan Pharmaceuticals and Healthcare Report

21 Sep 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: Economic and political challenges will continue to undermine growth within Sudan and South Sudan's pharmaceutical and healthcare markets. As such, political instability will remain a barrier to any significant investment in the sector, whilst disagreements about oil revenue sharing will af...

$ 1,295.00

Read More

Pakistan Pharmaceuticals and Healthcare Report

21 Sep 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: Pakistan's pharmaceutical market will remain a low priority for innovative drugmakers. Downward price pressures on pharmaceutical prices coupled with uncertainty surrounding the country's policy direction impinge on potential commercial opportunities, while a fragmented procurement system ...

$ 1,295.00

Read More

Singapore Pharmaceuticals and Healthcare Report

21 Sep 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: The delivery of healthcare in Singapore will continue to change as the country looks to deepen the integration of technology with its medical sector. This will see a shift in the flow of patients seeking medical services, their interaction with physicians and potentially the use of pharmac...

$ 1,295.00

Read More

Iraq Pharmaceuticals and Healthcare Report

21 Sep 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: Iraq's ailing domestic landscape will dampen investor confidence in the country's pharmaceuticals and healthcare sectors over at least the next few years if not longer. Although the government remains committed to healthcare provision, economic and security headwinds will mean internationa...

$ 1,295.00

Read More

Serbia Pharmaceuticals and Healthcare Report

21 Sep 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: Serbia will remain an unattractive market for multinational drugmakers in comparison to its regional neighbours. Government cost-containment, via severe drug price cuts, and continued economic issues will dampen the country's growth outlook.Headline Expenditure ProjectionsPharmaceuticals: ...

$ 1,295.00

Read More

Switzerland Pharmaceuticals and Healthcare Report

21 Sep 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: Switzerland will remain amongst the wealthiest countries in the world in real GDP per capita terms, which together with an aging population and a preference for patented medicines, will keep pharmaceutical spending high. However, faced with growing healthcare costs, the Swiss government wi...

$ 1,295.00

Read More

Oman Pharmaceuticals and Healthcare Report

21 Sep 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: The Oman Ministry of Health's decision to postpone the latest phase of medicine price reductions highlights the opaque nature of the country's pharmaceutical sector. Over the long term, Oman's population will benefit from more affordable healthcare services as even more medicines are reduc...

$ 1,295.00

Read More

Puerto Rico Pharmaceuticals and Healthcare Report

21 Sep 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: An expected increase in US government funding to strengthen Puerto Rico's healthcare system will support pharmaceutical and healthcare sector growth in the commonwealth over the next few years. While the US administration will continue to seek legislative removal of Puerto Rico's Medicaid ...

$ 1,295.00

Read More

Sweden Pharmaceuticals and Healthcare Report

21 Sep 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: Declining government reimbursement for prescription medicines and the promotion of lowervalue generic medicines does not bode well for innovative drugmakers selling their products in Sweden, particularly as the government is the primary purchaser of pharmaceuticals. Over the long term, pus...

$ 1,295.00

Read More

Pharmaceutical Excipients Global Market - Forecast to 2022

16 Sep 2016  |  Published by:  IQ4I Research and Consultancy
Pharmaceutical excipients are inactive substances in the drug which helps in modulating solubility, bioavailability and stability of active substances for formulating final drug dosage forms. The excipients form the major part of any medicinal product and proportion of it when compared to Active Pha...

$ 4,500.00
$ 4,050.00
( Save 10% )

Read More

Medical Holography Market by Product (Holographic Display, Microscope, Print, Software), Application (Medical Imaging, Medical Education, Biomedical Research), End User (Medical Schools, Pharmaceutical Companies, Hospitals) - Global Forecast to 2021

16 Sep 2016  |  Published by:  MarketsandMarkets
The global medical holography market is projected to reach USD 953.9 million by 2021, growing at a CAGR of 33.7% from 2016 to 2021. Growth in this market can be attributed to a number of factors such as rising adoption of holography products in biomedical research and medical education, growing clin...

$ 5,650.00

Read More

Mozambique Pharmaceuticals and Healthcare Report

14 Sep 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: Mozambique will continue to be one of the least attractive pharmaceutical and healthcare markets in the Middle East and Africa region (MEA). The escalation of political violence has directly impacted health centres in some of the country's provinces leading to the further deterioration of ...

$ 1,295.00

Read More

Sri Lanka Pharmaceuticals and Healthcare Report

14 Sep 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: Sri Lanka's pharmaceutical and healthcare markets will continue to expand over the next 10 years driven by economic development. Despite an increased level of fiscal tightening in the coming quarters, healthcare system strengthening and facilities upgrade will remain a policy priority. We ...

$ 1,295.00

Read More

Morocco Pharmaceuticals and Healthcare Report

14 Sep 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: The Moroccan government's strategy of introducing pharma-clusters in an attempt to strengthen the domestic pharmaceutical industry will see the market develop into a more attractive investment destination for multinational drugmakers. The use of pharma-clusters to boost local production ca...

$ 1,295.00

Read More

Chile Pharmaceuticals and Healthcare Report

14 Sep 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: Chile's healthcare reform and sector investment will continue to expand the role of the state in the provision of health services and medicines. The stable political and economic outlook in Chile provides a solid foundation for the government to launch assistance programmes such as the 'Pe...

$ 1,295.00

Read More
Total 24829 records.